Millions
of people around the world suffer from nearsightedness, which means they have
to use glasses to study.
But
the good news is that very soon such people will not need glasses for near
vision problems, as an experimental eye drop has emerged as the solution.
The
US Food and Drug Administration has a new iDrop AGN. 190584 has been submitted
for approval.
Tired
of reading glasses? Eye drop submitted for FDA approval may help you read
without them.
According
to a statement issued by a company called Allergen Eye Care, this eye drop is
likely to be approved this year.
This
eye drop is designed to treat the symptoms of presbyopia, a vision disorder
that weakens the ability of the eyes to focus on nearby objects as they age.
According
to experts, this problem of vision can start from the age of 10 and the ability
to focus can be completely lost by the age of 70, however, most patients
realize it in the 5th decade of age.
In
this condition, the lens of the eye begins to lose its elasticity, which makes
it difficult for it to change its structure, making it possible to see distant
objects clearly, but not distant objects or attention during the study. It
becomes difficult to focus.
This
eye drop is not primarily to treat the cause of the disease but to help cure
its symptoms.
That
is, instead of eye lenses, these drops will shorten the pupils of the eyes and
create a pinhole effect, which will increase the ability to focus.
According
to experts, if you have a camera and you reduce its aperture and allow some
light to come in, your ability to focus on objects will increase, the same
thing happens with the eyes and away from the pinhole effect. At the same time,
it is possible to see the nearby objects.
Two
trials of the new drug were performed on 750 people between the ages of 40 and
55, divided into two groups, one with eye drops and the other with a placebo
once a day for 30 days.
The
results showed that these eye drops were safe and effective, while the
participants in the trial were able to read 3 lines of words on the chart in
low light, while the people in the placebo group failed to do so.
These
eye drops to eliminate the need for glasses within 15 minutes of being inserted
into the eye, but their efficacy takes more than an hour to reach their peak.
Less
than 5% of people with side effects experienced headaches, redness of the eyes,
blurred vision, and some eye pain.
If
approved, it would be the first eye drops to treat presbyopia.
This
eye drop should be used once a day or this number may be higher if needed.
Further trials will be conducted to see how the drug will work if used more
than once a day.
According
to the company, these eye drops are currently given to people over 40 to 50
years of age who have a mild or moderate visual impairment.
But soon,
it will be tried on elderly patients as well.
“We
don’t think this eye drop will eliminate reading glasses, but it’s a good
tool,” the company said.
Comments